Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer.

MLA

Standing, David, et al. “Selective Targeting of IRAK1 Attenuates Low Molecular Weight Hyaluronic Acid-Induced Stemness and Non-Canonical STAT3 Activation in Epithelial Ovarian Cancer.” Cell Death & Disease, vol. 15, no. 5, May 2024, p. 362. EBSCOhost, https://doi.org/10.1038/s41419-024-06717-3.

APA

Standing, D., Dandawate, P., Gunewardena, S., Covarrubias-Zambrano, O., Roby, K. F., Khabele, D., Jewell, A., Tawfik, O., Bossmann, S. H., Godwin, A. K., Weir, S. J., Jensen, R. A., & Anant, S. (2024). Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell Death & Disease, 15(5), 362. https://doi.org/10.1038/s41419-024-06717-3

Chicago

Standing, David, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F Roby, Dineo Khabele, Andrea Jewell, et al. 2024. “Selective Targeting of IRAK1 Attenuates Low Molecular Weight Hyaluronic Acid-Induced Stemness and Non-Canonical STAT3 Activation in Epithelial Ovarian Cancer.” Cell Death & Disease 15 (5): 362. doi:10.1038/s41419-024-06717-3.